1
|
Umeda Y, Izawa T, Kazama K, Arai S, Kamiie J, Nakamura S, Hano K, Takasu M, Hirata A, Rittinghausen S, Yamano S. Comparative anatomy of respiratory bronchioles and lobular structures in mammals. J Toxicol Pathol 2025; 38:113-129. [PMID: 40190622 PMCID: PMC11966126 DOI: 10.1293/tox.2024-0071] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2024] [Accepted: 12/19/2024] [Indexed: 04/09/2025] Open
Abstract
Rodents are widely used to study the toxicity of chemicals; however, differences between species indicate that the results from rodents are not always directly transferable to humans. The health of workers exposed to various chemicals and particulates at high doses or for long periods is at risk. Respiratory bronchioles and lobular structures, which are demarcated by interlobular septa, are key sites for occupational lung diseases such as pneumoconiosis; however, these structures vary among animal species. Understanding these differences is crucial for studying the pathology of human occupational lung diseases. However, there is a lack of reviews focusing on these structures in different species. This review explores the lung anatomy of various mammals and its functional importance in disease to connect animal studies with human occupational lung diseases. Our results indicate that artiodactyls, especially small pig breeds and goats, are ideal for research because their respiratory bronchioles and lobular structures are similar to those of humans. This review aims to enhance the use of experimental animal data and improve our understanding of human occupational lung diseases, thereby facilitating early disease detection, treatment, and prevention.
Collapse
Affiliation(s)
- Yumi Umeda
- National Institute of Occupational Safety and Health, Japan,
Organization of Occupational Health and Safety, 2-26-1 Muraoka-higashi, Fujisawa, Kanagawa
251-0015, Japan
| | - Takeshi Izawa
- Laboratory of Veterinary Pathology, Osaka Metropolitan
University Graduate School of Veterinary Science, 1-58 Rinku-Orai-Kita, Izumisano, Osaka
598-8531, Japan
| | - Kei Kazama
- Department of Veterinary Medicine, Azabu University, School
of Veterinary Medicine, 17-71 Fuchinobe 1-chome, Chuo-ku, Sagamihara 252-5201, Japan
| | - Sachiko Arai
- Department of Veterinary Medicine, Azabu University, School
of Veterinary Medicine, 17-71 Fuchinobe 1-chome, Chuo-ku, Sagamihara 252-5201, Japan
| | - Junichi Kamiie
- Laboratory of Veterinary Pathology, School of Veterinary
Medicine, Azabu University, 1-17-71 Fuchinobe, Chuo-ku, Sagamihara, Kanagawa 252-5201,
Japan
| | - Shinichiro Nakamura
- Laboratory of Laboratory Animal Science, School of
Veterinary Medicine, Azabu University, 1-17-71 Fuchinobe, Chuo-ku, Sagamihara, Kanagawa
252-5201, Japan
| | - Kazuki Hano
- Gifu University Institute for Advanced Study, Gifu
University, 1-1 Yanagido, Gifu 501-1193, Japan
| | - Masaki Takasu
- Gifu University Institute for Advanced Study, Gifu
University, 1-1 Yanagido, Gifu 501-1193, Japan
- Center for One Medicine Innovative Translational Research
(COMIT), Gifu University, 1-1 Yanagido, Gifu, 501-1193, Gifu, 501-1193, Japan
| | - Akihiro Hirata
- Center for One Medicine Innovative Translational Research
(COMIT), Gifu University, 1-1 Yanagido, Gifu, 501-1193, Gifu, 501-1193, Japan
- Laboratory of Veterinary Pathology, Joint Department of
Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu University, 1-1
Yanagido, Gifu, 501-1193, Japan
| | - Susanne Rittinghausen
- Fraunhofer Institute for Toxicology and Experimental
Medicine (ITEM), Nikolai-Fuchs-Strasse 1, 30625, Hannover, Germany
| | - Shotaro Yamano
- National Institute of Occupational Safety and Health, Japan,
Organization of Occupational Health and Safety, 2-26-1 Muraoka-higashi, Fujisawa, Kanagawa
251-0015, Japan
| |
Collapse
|
2
|
Ribeiro RVP, Altarabsheh SE, Segamanasinghe DL, Lopez-Muralles IW, Garcia Moreno AS, Knop G, Al-Azzam F, Mallea J, Brownfield DG, Olson AC, Gibbard DF, Jing Y, Cheng K, Saddoughi SA. Preconditioning donor lungs with lung-derived exosomes mitigates ischemia-reperfusion injury in a warm ischemia porcine DCD model. J Heart Lung Transplant 2025:S1053-2498(25)01856-X. [PMID: 40127773 DOI: 10.1016/j.healun.2025.03.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2024] [Revised: 03/16/2025] [Accepted: 03/18/2025] [Indexed: 03/26/2025] Open
Abstract
BACKGROUND Donation after circulatory death (DCD) donors remain an underutilized source in the United States due to concerns of ischemia-reperfusion injury (IRI) after prolonged ischemic times. Lung-derived exosomes have shown potential in mitigating pulmonary fibrosis by promoting lung repair. Here, we sought to investigate the potential of lung-derived exosomes to prevent and repair lung IRI. METHODS We used a porcine DCD model to induce lung injury. Following the determination of optimal warm ischemic time (WIT), donor pigs were allocated into 3 study groups (n = 5, each): control, pre-DCD exosome treatment, and post-DCD exosomes treatment. Lungs were assessed using ex-vivo lung perfusion (EVLP) for functional parameters, histologic evaluation, and molecular analysis of inflammatory markers and oxidative stress. RESULTS A 1-hour WIT induced consistent lung injury, which was ameliorated with pre-DCD exosome treatment exhibiting significantly improved lung function during EVLP compared to controls. This group presented higher pO2, better lung compliance, lower airway pressures, and reduced pulmonary vascular resistance. Histologic analysis indicated reduced edema, vascular congestion, and leukocyte infiltration. Key inflammatory cytokines such as IL-6, IL-1β, and TNF-α were significantly downregulated, and reactive oxygen species levels were lower than controls. Despite inferior response compared to pre-DCD treatment, post-DCD exosome treatment also improved lung function and reduced edema formation, with significant decrease in inflammation. CONCLUSIONS Lung-derived exosome therapy significantly mitigates IRI in a porcine DCD model, improving lung function and reducing inflammation and oxidative stress. These findings support the potential of exosome therapy to increase donor lung utilization, warranting further mechanistic and clinical studies.
Collapse
Affiliation(s)
- Rafaela V P Ribeiro
- Division of Thoracic Surgery, Department of Surgery, Mayo Clinic, Rochester, Minnesota
| | | | | | | | - Ana S Garcia Moreno
- Division of Thoracic Surgery, Department of Surgery, Mayo Clinic, Rochester, Minnesota
| | - Gustavo Knop
- Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota
| | - Fuad Al-Azzam
- Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota
| | - Jorge Mallea
- Department of Critical Care Medicine, Mayo Clinic, Jacksonville, Florida
| | - Douglas G Brownfield
- Division of Pulmonary and Critical Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota
| | - Aaron C Olson
- Division of Pulmonary and Critical Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota
| | - Daniel F Gibbard
- Division of Pulmonary and Critical Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota
| | - Yujia Jing
- Xsome Biotech Inc., Raleigh, North Carolina
| | - Ke Cheng
- Department of Biomedical Engineering, Columbia University, New York City, New York
| | - Sahar A Saddoughi
- Division of Thoracic Surgery, Department of Surgery, Mayo Clinic, Rochester, Minnesota; Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota.
| |
Collapse
|
3
|
Clarke DO, Datta K, French K, Leach MW, Olaharski D, Mohr S, Strein D, Bussiere J, Feyen B, Gauthier BE, Graziano M, Harding J, Hershman K, Jacob B, Ji S, Lange R, Salian-Mehta S, Sayers B, Thomas N, Flandre T. Opportunities and challenges for use of minipigs in nonclinical pharmaceutical development: Results of a follow-up IQ DruSafe survey. Regul Toxicol Pharmacol 2024; 154:105729. [PMID: 39481797 DOI: 10.1016/j.yrtph.2024.105729] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2024] [Revised: 10/07/2024] [Accepted: 10/19/2024] [Indexed: 11/02/2024]
Abstract
Minipigs are valid nonrodent species infrequently utilized for pharmaceutical research and development (R&D) compared with dogs or nonhuman primates (NHPs). A 2022 IQ DruSafe survey revealed a modest increase in minipig use by pharmaceutical companies compared with a prior 2014 survey, primarily in the development of oral small molecules and parenteral protein molecules. Some companies considered using minipigs more often due to NHP shortages and regional ethical concerns with using NHPs and dogs. However, for most pharmaceutical companies, minipigs still represent ≤5% of their nonrodent animal use. Key challenges noted by companies to wider adoption of minipigs were high test article requirement, limited historical control data, and lack of relevant reagents or assays. Additionally, some companies expressed uncertainties about contract research organization (CRO) capabilities and experience, a perception not shared by respondent CROs. These latest survey results indicate persistence of many concerns previously identified in 2014. Several case studies are included to illustrate areas of expanded minipig use as well as the challenges that hinder broader adoption. Ongoing, focused, and industry-wide initiatives to address the identified or perceived challenges may lead to more frequent or routine consideration of minipigs as a test species in pharmaceutical R&D.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | - Bianca Feyen
- Johnson & Johnson Innovative Medicine, Beerse, Belgium
| | | | | | - Joanna Harding
- Exscientia (formerly represented Astra Zeneca), Oxford, UK
| | | | | | - Shaofei Ji
- Johnson & Johnson Innovative Medicine, Springhouse, PA, USA
| | | | | | | | | | | |
Collapse
|
4
|
Schafer KA, Atzpodien E, Bach U, Bartoe J, Booler H, Brassard J, Farman C, Kochi M, Lejeune T, Meseck E, Nolte T, Ramos M, Short B, Sorden S, Teixeira L, Turner O, Walling B, Yekkala K, Yoshizawa K. International Harmonization of Nomenclature and Diagnostic Criteria (INHAND): Nonproliferative and Proliferative Lesions of Nonrodent Ocular Tissues. Toxicol Pathol 2024; 52:368-455. [PMID: 39658869 PMCID: PMC11834351 DOI: 10.1177/01926233241283708] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2024]
Abstract
The INHAND (International Harmonization of Nomenclature and Diagnostic Criteria for Lesions) Project (www.toxpath.org/ inhand.asp) is a joint initiative of the Societies of Toxicologic Pathology from Europe (ESTP), Great Britain (BSTP), Japan (JSTP), and North America (STP) to develop an internationally accepted nomenclature for proliferative and nonproliferative lesions in laboratory animals. The purpose of this publication is to provide a standardized nomenclature for classifying lesions observed in ocular tissues (eyes and glands and ocular adnexa) from laboratory nonrodent species (rabbits, dogs, minipigs, and nonhuman primates) used in nonclinical safety studies with an emphasis on ocular-targeted dosing. Some of the lesions are illustrated by color photomicrographs. The standardized nomenclature presented in this document is also available electronically on the Internet (http://www.goreni.org/). Sources of material included histopathology databases from government, academia, and industrial laboratories throughout the world. Content includes descriptions and visual depictions of spontaneous lesions and lesions induced by exposure to various test materials. A widely accepted and utilized internationally harmonized nomenclature for lesions in laboratory animals will provide a common language among regulatory and scientific research organizations in different countries and increase and enrich international exchanges of information among toxicologists and pathologists.
Collapse
Affiliation(s)
- K. A. Schafer
- Greenfield Pathology Services, Inc., Greenfield, Indiana, USA
| | | | - U. Bach
- Bayer AG, Wuppertal, Germany
| | - J. Bartoe
- Horus Consulting, LLC, Spring Lake, Michigan, USA
| | - H. Booler
- Novartis Biomedical Research, Basel, Switzerland
| | - J. Brassard
- Brassard Toxicologic Pathology Consultancy, Tustin, California, USA
| | - C. Farman
- Greenfield Pathology Services, Inc., Greenfield, Indiana, USA
| | - M. Kochi
- Sumitomo Pharma Co., Ltd., Osaka, Japan
| | - T. Lejeune
- Charles River Montreal ULC, Senneville, Quebec, Canada
| | - E. Meseck
- Novartis Biomedical Research, East Hanover, New Jersey, USA
| | - T. Nolte
- Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany
| | | | - B. Short
- Brian Short Consulting, LLC, Laguna Beach, California, USA
| | | | - L. Teixeira
- University of Wisconsin-Madison, Madison, Wisconsin, USA
| | - O. Turner
- Novartis Biomedical Research, East Hanover, New Jersey, USA
| | - B. Walling
- Charles River Laboratories, Ashland, Ohio, USA
| | - K. Yekkala
- Johnson & Johnson Innovative Medicine, Springhouse, Pennsylvania, USA
| | | |
Collapse
|
5
|
Ramot Y, Karakuz V, Willenz EP, Alon T, Barzilai DZ, Beer O, Nyska A. Comprehensive Evaluation of the BeShape One Device: Assessing Thermal Safety in Noninvasive Body Contouring Using Advanced Techniques. Lasers Surg Med 2024; 56:581-591. [PMID: 38888133 DOI: 10.1002/lsm.23818] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2024] [Revised: 06/05/2024] [Accepted: 06/05/2024] [Indexed: 06/20/2024]
Abstract
OBJECTIVES This study aims to assess the thermal safety profile of the BeShape One Device, a noninvasive, high-intensity, non-focused ultrasound device designed for reducing waist circumference. This device possesses several features that distinguish it from other commercial ultrasound-based fat reduction devices. The study focuses on evaluating temperature-related physiological changes through thermal safety analysis and histopathology in a swine model. MATERIALS AND METHODS The study utilized three types of applicators-active, demo, and modified-to comprehensively assess the device's impact on various skin layers. Five female Large White X Landrace swine were involved in the study, and the BeShape One Device was applied to designated treatment sites using a specific treatment protocol. The assessment included clinical observations, skin reaction evaluations, gross pathology, histopathological analyses, and advanced temperature measurement techniques, including needle thermocouples, thermal cameras, COMSOL modeling, and CEM43 analysis. RESULTS Clinical observations indicated the animals' overall well-being throughout the study. Skin reactions, including erythema, edema, bruising, and crust formation, were temporary and resolved over time. Gross pathology revealed no treatment-related pathologies, except for a discoloration related to a tattoo procedure. Histopathological analyses at 30 and 90 days posttreatment demonstrated an absence of heat-related lesions in skin layers. Needle thermocouples and thermal camera measurements supported the device's ability to maintain consistent thermal homogeneity. COMSOL modeling and CEM43 analysis predicted no thermal damage to the skin, confirming the safety of the BeShape One Device. CONCLUSIONS Under the experimental conditions, the BeShape One Device demonstrated a favorable safety profile. Clinically and histopathologically, no adverse effects were observed. The device's ability to achieve thermal homogeneity in skin layers was validated through advanced temperature measurement techniques. COMSOL modeling and CEM43 analysis further supported the conclusion that the device is safe, making it a promising option for noninvasive body contouring procedures.
Collapse
Affiliation(s)
- Yuval Ramot
- Department of Dermatology, Hadassah Medical Center, Jerusalem, Israel
- The Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
| | | | - Ehud P Willenz
- Pre-Clinical R&D Department, Shamir Medical Center (Assaf Harofeh), Zerifin, Israel
| | - Tal Alon
- Pre-Clinical R&D Department, Shamir Medical Center (Assaf Harofeh), Zerifin, Israel
| | | | - Oren Beer
- Pre-Clinical R&D Department, Shamir Medical Center (Assaf Harofeh), Zerifin, Israel
| | - Abraham Nyska
- Consultant in Toxicologic Pathology, Tel Aviv University, Tel Aviv, Israel
| |
Collapse
|
6
|
Grand N, Jeppesen G, Nyska A. Intra-abdominal Abscesses in Two Göttingen Minipigs. Toxicol Pathol 2024; 52:350-352. [PMID: 39417580 DOI: 10.1177/01926233241289112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2024]
Abstract
Minipigs are valued alternatives to dogs and non-human primates in non-clinical safety and toxicity studies, and Göttingen minipigs are bred specifically for experimental purposes. They are bred under barrier conditions and monitored regularly for many pathogens and opportunistic agents, and spontaneous disease is rare when compared to what is seen in production pigs. Knowledge of spontaneous background lesions is important when toxicological pathologists evaluate microscopic findings in pre-clinical toxicity studies to avoid interference with study data interpretation. In this brief communication, intra-abdominal granulomas/abscesses were seen in Göttingen minipigs. The minipigs did not show any clinical signs, but nodules were present in the abdominal peritoneum at necropsy. Microscopic evaluation revealed chronic inflammation, with abscess or granuloma formation. Areas of inflammation, occasionally associated with the presence of the Splendore-Hoeppli material, were surrounded by a fibrotic capsule. Special stains were applied to investigate for the presence of microorganisms.
Collapse
|
7
|
Bolon B, Gary JM. Toxicologic Pathology Forum: Apoptosis/Single Cell Necrosis as a Possible Procedural Effect in Primate Brain Following Ice-Cold Saline Perfusion. Toxicol Pathol 2024; 52:343-349. [PMID: 38661106 DOI: 10.1177/01926233241247044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/26/2024]
Abstract
Nonclinical studies of test articles (TAs) in nonhuman primates are often designed to assess both biodistribution and toxicity. For this purpose, studies commonly use intravenous perfusion of ice-cold (2°C-8°C) saline to facilitate measurements of TA-associated nucleic acids and proteins, after which tissues undergo later fixation by immersion for histological processing and microscopic evaluation. Intriguingly, minimal apoptosis/single cell necrosis (A/SCN) of randomly distributed neural cells is evident in the cerebral cortex and less often the hippocampus in animals from all groups, including vehicle-treated controls. Affected cells exhibit end-stage features such as cytoplasmic hypereosinophilia, nuclear condensation or fragmentation, and shape distortions, so their lineage(s) generally cannot be defined; classical apoptotic bodies are exceedingly rare. In addition, A/SCN is not accompanied by glial reactions, leukocyte infiltration/inflammation, or other parenchymal changes. The severity is minimal in controls but may be slightly exacerbated (to mild) by TA that accumulate in neural cells. One plausible hypothesis explaining this A/SCN exacerbation is that cold shock (perhaps complicated by concurrent tissue acidity and hypoxia) drives still-viable but TA-stressed cells to launch a self-directed death program. Taken together, these observations indicate that A/SCN in brain processed by cold saline perfusion with delayed immersion fixation represents a procedural artifact and not a TA-related lesion.
Collapse
|
8
|
Zha A, Li W, Wang J, Bai P, Qi M, Liao P, Tan B, Yin Y. Trimethylamine oxide supplementation differentially regulates fat deposition in liver, longissimus dorsi muscle and adipose tissue of growing-finishing pigs. ANIMAL NUTRITION (ZHONGGUO XU MU SHOU YI XUE HUI) 2024; 17:25-35. [PMID: 38464952 PMCID: PMC10920132 DOI: 10.1016/j.aninu.2023.12.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/08/2023] [Revised: 12/22/2023] [Accepted: 12/29/2023] [Indexed: 03/12/2024]
Abstract
Trimethylamine oxide (TMAO) is a microbiota-derived metabolite, and numerous studies have shown that it could regulate fat metabolism in humans and mice. However, few studies have focused on the effects of TMAO on fat deposition in growing-finishing pigs. This study aimed to investigate the effect of TMAO on fat deposition and intestinal microbiota in growing-finishing pigs. Sixteen growing pigs were randomly divided into 2 groups and fed with a basal diet with 0 or 1 g/kg TMAO for 149 d. The intestinal microbial profiles, fat deposition indexes, and fatty acid profiles were measured. These results showed that TMAO supplementation had a tendency to decrease lean body mass (P < 0.1) and significantly increased backfat thickness (P < 0.05), but it did not affect growth performance. TMAO significantly increased total protein (TP) concentration, and reduced alkaline phosphatase (ALP) concentration in serum (P < 0.05). TMAO increased the α diversity of the ileal microbiota community (P < 0.05), and it did not affect the colonic microbial community. TMAO supplementation significantly increased acetate content in the ileum, and Proteobacteria and Escherichia-Shigella were significantly enriched in the TMAO group (P < 0.05). In addition, TMAO decreased fat content, as well as the ratio of linoleic acid, n-6 polyunsaturated fatty acids (PUFA), and PUFA in the liver (P < 0.05). On the contrary, TMAO increased intramuscular fat content of the longissimus dorsi muscle, whereas the C18:2n6c ratio was increased, and the n-6 PUFA:PUFA ratio was decreased (P < 0.05). In vitro, 1 mM TMAO treatment significantly upregulated the expression of FASN and SREBP1 in C2C12 cells (P < 0.05). Nevertheless, TMAO also increased adipocyte area and decreased the CPT-1B expression in subcutaneous fat (P < 0.05). Taken together, TMAO supplementation regulated ileal microbial composition and acetate production, and regulated fat distribution and fatty acid composition in growing-finishing pigs. These results provide new insights for understanding the role of TMAO in humans and animals.
Collapse
Affiliation(s)
- Andong Zha
- Laboratory of Animal Nutritional Physiology and Metabolic Process, Key Laboratory of Agro-ecological Processes in Subtropical Region, National Engineering Laboratory for Pollution Control and Waste Utilization in Livestock and Poultry Production, Institute of Subtropical Agriculture, Chinese Academy of Sciences, Changsha 410125, China
- University of Chinese Academy of Sciences, Beijing 100008, China
| | - Wanquan Li
- College of Animal Science and Technology, Hunan Agricultural University, Changsha 410128, China
| | - Jing Wang
- College of Animal Science and Technology, Hunan Agricultural University, Changsha 410128, China
| | - Ping Bai
- Yunnan Southwest Agriculture and Animal Husbandry Group Co., Ltd, Kunming 650224, China
| | - Ming Qi
- Laboratory of Animal Nutritional Physiology and Metabolic Process, Key Laboratory of Agro-ecological Processes in Subtropical Region, National Engineering Laboratory for Pollution Control and Waste Utilization in Livestock and Poultry Production, Institute of Subtropical Agriculture, Chinese Academy of Sciences, Changsha 410125, China
- University of Chinese Academy of Sciences, Beijing 100008, China
| | - Peng Liao
- Laboratory of Animal Nutritional Physiology and Metabolic Process, Key Laboratory of Agro-ecological Processes in Subtropical Region, National Engineering Laboratory for Pollution Control and Waste Utilization in Livestock and Poultry Production, Institute of Subtropical Agriculture, Chinese Academy of Sciences, Changsha 410125, China
| | - Bie Tan
- College of Animal Science and Technology, Hunan Agricultural University, Changsha 410128, China
| | - Yulong Yin
- Laboratory of Animal Nutritional Physiology and Metabolic Process, Key Laboratory of Agro-ecological Processes in Subtropical Region, National Engineering Laboratory for Pollution Control and Waste Utilization in Livestock and Poultry Production, Institute of Subtropical Agriculture, Chinese Academy of Sciences, Changsha 410125, China
- College of Animal Science and Technology, Hunan Agricultural University, Changsha 410128, China
- University of Chinese Academy of Sciences, Beijing 100008, China
- Yunnan Southwest Agriculture and Animal Husbandry Group Co., Ltd, Kunming 650224, China
| |
Collapse
|
9
|
Kim HS, Kang GH, Yang MJ, Joo YJ, Lee DG, Lee HS, Lee JS, Hwang JH. Toxicity of a novel antifungal agent (ATB1651 gel) in Yucatan minipigs (Sus scrofa) following 4 weeks of daily dermal administration. Toxicol Res 2024; 40:247-258. [PMID: 38525130 PMCID: PMC10959866 DOI: 10.1007/s43188-023-00222-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2023] [Revised: 12/04/2023] [Accepted: 12/11/2023] [Indexed: 03/26/2024] Open
Abstract
ATB1651 gel is an antifungal drug candidate that enhances antifungal activity through substitution of several aryl rings, alkyl chains, and methyl groups. To ensure safety of use of ATB1651 gel, assessment of its potentially toxic side effects is necessary. In this study, we examined the repeated-dose toxicity of ATB1651 gel to Yucatan minipigs (Sus scrofa) in accordance with the Good Laboratory Practice guidelines. Five doses of ATB1651 gel (0%, 0.2%, 0.5%, 1.0%, 3.0%) were administered dermally to the left and right flanks of 38 minipigs daily for 4 weeks. Mortality, clinical symptoms, dermal scores, body weights, and physiological, biochemical, pathological, and toxicokinetic analyses were performed after the treatment period. No systemic toxicological damage was observed in either male or female minipigs regardless of dose; however, dermal application of ATB1651 gel caused some skin alterations at the application sites. Specifically, erythema and eschar formation, edema, and scabs or raise spots were observed at the application site(s) in males in the 3.0% ATB1651 gel treatment group and in females at ATB1651 gel concentrations ≥ 1.0%, with dermal scores ranging from grade 1 to 2. Additionally, histopathological assay indicated infiltration of different types of inflammatory cells and the presence of pustule/crust at the application site(s) in both males and females at ATB1651 gel concentrations ≥ 0.5%. However, these changes were reversible after a 2-week recovery period and were considered a local irritation effect of ATB1651 gel. The no-observed-adverse-effect level of ATB1651 gel was 3.0% with regard to topical and systemic toxicity in both male and female minipigs. Collectively, our results imply that ATB1651 gel is a safe candidate for clinical development as an antifungal drug with a wide therapeutic window.
Collapse
Affiliation(s)
- Hyung-Sun Kim
- Animal Model Research Group, Jeonbuk Branch Institute, Korea Institute of Toxicology, Jeongup, Jeonbuk 56212 Republic of Korea
| | - Goo-Hwa Kang
- Animal Model Research Group, Jeonbuk Branch Institute, Korea Institute of Toxicology, Jeongup, Jeonbuk 56212 Republic of Korea
| | - Mi-Jin Yang
- Jeonbuk Pathology Research Group, Jeonbuk Branch Institute, Korea Institute of Toxicology, Jeongup, Jeonbuk 56212 Republic of Korea
| | - Yun-Jeong Joo
- Jeonbuk Quality Assurance Unit, Jeonbuk Branch Institute, Korea Institute of Toxicology, Jeongup, Jeonbuk 56212 Republic of Korea
| | - Dong-Gi Lee
- AmtixBio Co., Ltd., Hanam-si, Gyeonggi-do 12925 Republic of Korea
| | - Han-Seung Lee
- AmtixBio Co., Ltd., Hanam-si, Gyeonggi-do 12925 Republic of Korea
| | - Jong-Seung Lee
- AmtixBio Co., Ltd., Hanam-si, Gyeonggi-do 12925 Republic of Korea
| | - Jeong Ho Hwang
- Animal Model Research Group, Jeonbuk Branch Institute, Korea Institute of Toxicology, Jeongup, Jeonbuk 56212 Republic of Korea
| |
Collapse
|
10
|
McKnight CA, Diehl LJ, Bergin IL. Digestive Tract and Salivary Glands. HASCHEK AND ROUSSEAUX' S HANDBOOK OF TOXICOLOGIC PATHOLOGY 2024:1-148. [DOI: 10.1016/b978-0-12-821046-8.00001-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/02/2025]
|
11
|
Ribeiro RVP, Reynolds FA, Sarrafian TL, Spadaccio C, Colby C, Richman A, Brazzell JL, Ergi DG, Altarabsheh S, Daxon BT, Cypel M, Saddoughi SA. Impact of normothermic regional perfusion during DCD recovery on lung allograft function: A preclinical study. JHLT OPEN 2023; 2:100009. [PMID: 40144014 PMCID: PMC11935417 DOI: 10.1016/j.jhlto.2023.100009] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 03/28/2025]
Abstract
Background Normothermic regional perfusion (NRP) has been growing as a novel procurement strategy after circulatory death (donation after circulatory death (DCD)) in the context of heart transplantation. However, the impact of NRP on lung graft viability is largely unknown. We sought to determine lung function after thoraco-abdominal NRP (TA-NRP) in a clinically relevant porcine DCD model. Methods Donor domestic pigs underwent hypoxic cardiac arrest to simulate DCD procurement and were randomly allocated to either 1-hour resuscitation on TA-NRP (n = 4) or direct lung procurement (direct procurement and perfusion (DPP), n = 4). All lungs were placed on ex-vivo lung perfusion (EVLP) and evaluated for 3 hours to assess functional outcome parameters and suitability for transplantation. Results After 1 hour of TA-NRP, cardiopulmonary bypass was weaned, and mean systemic PaO2/fraction of inspired oxygen was 418 ± 76 mm Hg, which was comparable to baseline (467 ± 41, p = 0.41). No significant differences were seen between the groups during EVLP, except for a higher pulmonary artery pressure in the TA-NRP group at 3 hours of EVLP (19.7 ± 1.5 vs 14.7 ± 2.1 mm Hg, p = 0.02). Perfusate inflammatory cytokines levels of IL-6 and IL-8 were higher at the first hour of EVLP in the TA-NRP group; however, these differences were not sustained as levels were similar by the last hour of EVLP. There were no differences in histology, cytokines, or metabolic profile of the TA-NRP lungs compared to DPP. Conclusions TA-NRP porcine lungs met functional criteria to proceed to transplantation and demonstrated no significant histological, cytokine, and metabolic differences when compared to DPP porcine lungs. This study highlights the value of considering TA-NRP lungs for transplant with well-established protocols.
Collapse
Affiliation(s)
- Rafaela V P Ribeiro
- Division of Thoracic Surgery, Department of Surgery, Mayo Clinic, Rochester, Minnesota
| | - Frank A Reynolds
- Department of Cardiovascular Perfusion, Mayo Clinic, Rochester, Minnesota
| | - Tiffany L Sarrafian
- Division of Thoracic Surgery, Department of Surgery, Mayo Clinic, Rochester, Minnesota
| | | | - Clint Colby
- Department of Cardiovascular Perfusion, Mayo Clinic, Rochester, Minnesota
| | - Adam Richman
- Department of Cardiovascular Perfusion, Mayo Clinic, Rochester, Minnesota
| | | | - Defne Gunes Ergi
- Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota
| | - Salah Altarabsheh
- Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota
| | - Benjamin T Daxon
- Department of Anesthesiology & Perioperative Medicine, Mayo Clinic, Rochester, Minnesota
| | - Marcelo Cypel
- Toronto General Hospital, University Health Network, Toronto, Ontario, Canada
| | - Sahar A Saddoughi
- Division of Thoracic Surgery, Department of Surgery, Mayo Clinic, Rochester, Minnesota
- Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota
| |
Collapse
|
12
|
Bolon B. Toxicologic Pathology Forum Opinion: Rational Approaches to Expanded Neurohistopathology Evaluation for Nonclinical General Toxicity Studies and Juvenile Animal Studies. Toxicol Pathol 2023; 51:363-374. [PMID: 38288942 DOI: 10.1177/01926233231225239] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/10/2024]
Abstract
Existing nervous system sampling and processing "best practices" for nonclinical general toxicity studies (GTS) were designed to assess test articles with unknown, no known, or well-known neurotoxic potential. Similar practices are applicable to juvenile animal studies (JAS). In GTS and JAS, the recommended baseline sampling for all species includes brain (7 sections), spinal cord (cervical and lumbar divisions [cross and longitudinal sections for each]), and 1 nerve (sciatic or tibial [cross and longitudinal sections]) in hematoxylin and eosin-stained sections. Extra sampling and processing (ie, an "expanded neurohistopathology evaluation" [ENHP]) are used for agents with anticipated neuroactivity (toxic ± therapeutic) of incompletely characterized location and degree. Expanded sampling incorporates additional brain (usually 8-15 sections total), spinal cord (thoracic ± sacral divisions), ganglia (somatic ± autonomic, often 2-8 total), and/or nerves (2-6 total) depending on the species and study objectives. Expanded processing typically adds special neurohistological procedures (usually 1-4 for selected samples) to characterize glial reactions, myelin integrity, and/or neuroaxonal damage. In my view, GTS and JAS designs should sample neural tissues at necropsy as if ENHP will be needed eventually, and when warranted ENHP may incorporate expanded sampling and/or expanded processing depending on the study objective(s).
Collapse
|
13
|
Inoue M, Miyazaki S, Kobayashi N, Kangawa A, Murakami T. Pathological Characterization of Spontaneous AA Amyloidosis in Microminipigs. Toxicol Pathol 2023; 51:257-263. [PMID: 37873595 DOI: 10.1177/01926233231204019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2023]
Abstract
The minipig has been used as a non-rodent species in nonclinical toxicology studies, but little is known about amyloid A (AA) amyloidosis in this species. Among domestic pigs, reports of AA amyloidosis have been limited to animals with mutations in the N-terminal residue of serum AA (SAA), which is thought to be a primary etiological factor. In this study, we histologically examined 26 microminipigs aged 0.6 to 10 years and observed amyloid deposition in one 0.6-year-old and six 5-year-old or older microminipigs. The amyloid deposits were identified as AA based on mass spectrometry (MS) and immunohistochemistry (IHC). The 0.6-year-old microminipig showed severe deposition in the renal cortex and spleen, whereas 5-year-old or older animals had severe deposition in the renal medulla. MS and IHC detected serum amyloid P-component (SAP) in amyloid deposits in older animals but not in a 0.6-year-old animals. Based on the proteomic analysis and gene sequencing, amino acid mutations of SAA, previously found in domestic pigs, were not involved in the pathogenesis of AA amyloidosis in microminipigs. This study demonstrates that microminipigs with wild-type SAA develop AA amyloidosis and presents the possibility that differences in the environment surrounding amyloid, such as SAP, may influence differences in the pathological phenotype.
Collapse
Affiliation(s)
- Misaki Inoue
- Tokyo University of Agriculture and Technology, Tokyo, Japan
| | - Shinya Miyazaki
- Tokyo University of Agriculture and Technology, Tokyo, Japan
| | | | | | | |
Collapse
|
14
|
Feller LE, Sargeant A, Ehrhart EJ, Balmer B, Nelson K, Lamoureux J. Cardiac Rhabdomyoma in Four Göttingen Minipigs. Toxicol Pathol 2023; 51:61-66. [PMID: 36726336 DOI: 10.1177/01926233221148393] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
Göttingen minipigs are increasingly used as an alternative large animal model in nonclinical toxicology studies, and proliferative lesions in this species are rare. Here, we report four cases of cardiac rhabdomyoma in Göttingen minipigs, an incidental and benign mass in the heart. Three cases lacked gross observations and had a microscopic nodule in either the left ventricle or interventricular septum. The last case had a large, firm, raised nodule on a left ventricular papillary muscle noted at necropsy, with additional microscopic intramural masses in the left ventricular wall. In all cases, microscopic evaluation revealed well-circumscribed, expansile nodules composed of bundles of large, highly vacuolated, ovoid to polygonal cells with variable cytoplasmic processes radiating from a centrally located nucleus. Cells displayed patchy accumulation of intracytoplasmic, PAS-positive material and haphazardly arranged cytoplasmic cross-striations. There was no evidence of cardiac insufficiency or other data to suggest the masses were clinically meaningful. Cardiac rhabdomyomas have been reported in meat-hybrid swine, with a breed predisposition in red wattle. This lesion is well established in guinea pigs, but documentation in other laboratory species used in toxicologic studies is limited to two beagle dogs. To our knowledge, this is the first report of spontaneous cardiac rhabdomyoma in Göttingen minipigs.
Collapse
Affiliation(s)
- Laine E Feller
- Cornell University, Ithaca, New York, USA
- Johns Hopkins University, Baltimore, Maryland, USA
| | | | - E J Ehrhart
- Charles River Laboratories, Spencerville, Ohio, USA
| | | | - Keith Nelson
- Charles River Laboratories, Mattawan, Michigan, USA
- Inotiv, St. Louis, Missouri, USA
| | - Jennifer Lamoureux
- Charles River Laboratories, Mattawan, Michigan, USA
- Inotiv, St. Louis, Missouri, USA
| |
Collapse
|
15
|
Biddle KE. Opinion on the Optimal Histologic Evaluation of the Bone Marrow in Nonclinical Toxicity Studies. Toxicol Pathol 2021; 50:266-273. [PMID: 34875926 DOI: 10.1177/01926233211061712] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Identification of bone marrow toxicity is an important issue in drug development and toxicologic pathologists play a critical role in that identification. Knowledge of the general components of bone marrow, relevant anatomical and species differences, and the standard approach (routine systematic histological evaluation of the bone marrow in conjunction with analysis of the peripheral complete blood count data) will be reviewed. Specific morphologic features that anatomic pathologists should look for in the various components of bone marrow as well as suggested terminology for bone marrow findings will be discussed. Finally, an opinion on the limitations of the standard approach to bone marrow evaluation will be provided including general recommendations on when additional methods (image analysis of hematoxylin and eosin stained slides, flow cytometry or Sysmex XT 2000iV analysis, cytological evaluation of bone marrow smears, in vitro models, and transmission electron microscopy) might be useful in the detection or further characterization of bone marrow toxicity. [Box: see text].
Collapse
|
16
|
Coe SE, Thellman S, Petticoffer A, Pielemeier R, Nelson K. Mucocutaneous Squamous Cell Carcinoma in a Yucatan Minipig. Toxicol Pathol 2021; 50:158-160. [PMID: 34328045 DOI: 10.1177/01926233211036068] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Minipigs are commonly utilized in dermal toxicology studies, necessitating documentation of background findings, including neoplastic lesions. We describe a case of a Yucatan minipig with a squamous cell carcinoma at the mucocutaneous junction of the lip. The neoplasm appeared grossly as a slightly raised area of skin with ulceration. Histologically, there were nests and trabeculae of neoplastic squamous epithelial cells undergoing keratinization. Multifocally, rafts of these cells were within lymphatic vessels. Squamous cell carcinoma has not previously been reported in Yucatan or other laboratory minipigs, however, has been reported uncommonly in nonlaboratory pot-bellied pigs. Although squamous cell carcinoma has been associated with ultraviolet exposure or papillomavirus in various species, this was unable to be confirmed in this case.
Collapse
Affiliation(s)
- Sarah E Coe
- Department of Pathobiology and Diagnostic Investigation, Michigan State University, Lansing, MI, USA.,Charles River Laboratories, Mattawan, MI, USA
| | | | | | | | | |
Collapse
|